Replication data for: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India

Mark Duggan, Craig Garthwaite & Aparajita Goyal
In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent, with larger increases for more recently developed molecules and for those produced by just one firm when...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.